Edition:
United States

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

3.39USD
23 Apr 2018
Change (% chg)

$-0.05 (-1.45%)
Prev Close
$3.44
Open
$3.44
Day's High
$3.54
Day's Low
$3.36
Volume
43,970
Avg. Vol
271,921
52-wk High
$5.82
52-wk Low
$1.59

Latest Key Developments (Source: Significant Developments)

Htg Molecular Diagnostics Secures Debt Facility With Midcap Financial
Tuesday, 27 Mar 2018 08:00am EDT 

March 27 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS SECURES DEBT FACILITY WITH MIDCAP FINANCIAL.HTG MOLECULAR DIAGNOSTICS INC - ‍ENTERED INTO A SENIOR DEBT FACILITY WITH MIDCAP FINANCIAL TO REPLACE ITS EXISTING SENIOR CREDIT FACILITY.HTG MOLECULAR DIAGNOSTICS INC - ‍DURATION OF TERM LOAN IS FIVE YEARS, WITH INTEREST ONLY PAYMENTS FOR FIRST TWO YEARS​.HTG MOLECULAR DIAGNOSTICS - ‍SENIOR FACILITY ALSO INCLUDES AN INITIAL $2.0 MILLION REVOLVING LINE OF CREDIT, SECURED BY ACCOUNTS RECEIVABLE AND INVENTORY​.HTG MOLECULAR DIAGNOSTICS INC - ‍REVOLVING LINE OF CREDIT IS EXPANDABLE TO UP TO $10.0 MILLION UNDER CERTAIN CONDITIONS OVER A FIVE-YEAR PERIOD​.HTG MOLECULAR DIAGNOSTICS-UP TO $30.0 MILLION CREDIT FACILITY CONSISTS OF $7.0 MILLION TERM LOAN WITH ABILITY TO ACCESS ANOTHER $13.0 MILLION ADDITIONAL TRANCHE.  Full Article

HTG Molecular Q4 Loss Per Share $0.15
Thursday, 22 Mar 2018 04:01pm EDT 

March 22 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS.Q4 LOSS PER SHARE $0.15.Q4 REVENUE $7.9 MILLION VERSUS $1.5 MILLION.  Full Article

HTG Molecular Diagnostics Intends To Offer 10 mln shares of common stock
Tuesday, 16 Jan 2018 04:01pm EST 

Jan 16 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.HTG MOLECULAR DIAGNOSTICS - ‍INTENDS TO OFFER AND SELL, 10 MILLION SHARES OF COMMON STOCK IN UNDERWRITTEN PUBLIC OFFERING​.  Full Article

HTG Announces Preliminary Q4 And Full Year 2017 Unaudited Financial Results
Thursday, 4 Jan 2018 08:00am EST 

Jan 4 (Reuters) - HTG Molecular Diagnostics Inc ::HTG ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 UNAUDITED FINANCIAL RESULTS AND PROVIDES INITIAL 2018 REVENUE GUIDANCE.SEES Q4 2017 REVENUE $6.9 MILLION TO $7.2 MILLION.SEES FY 2017 REVENUE $13.8 MILLION TO $14.1 MILLION.SEES FY 2018 REVENUE $20 MILLION TO $25 MILLION.  Full Article

HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement
Wednesday, 27 Dec 2017 04:35pm EST 

Dec 27 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT.HTG MOLECULAR DIAGNOSTICS SAYS UNDER PLAN, ILLUMINA EXPECTED TO DEVELOP & DELIVER TO CO EXECUTABLE VERSION OF CUSTOM SOFTWARE - SEC FILING.  Full Article

HTG Molecular Diagnostics Expands Its Collaboration With Merck
Tuesday, 26 Dec 2017 04:01pm EST 

Dec 26 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS EXPANDS ITS COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY.HTG MOLECULAR - TO DEVELOP CUSTOM PROFILING ASSAY TO SUPPORT BIOMARKER RESEARCH FOR 6 INDICATIONS WITHIN MERCK KGAA'S DRUG DEVELOPMENT PIPELINE.  Full Article

HTG Molecular Diagnostics And Unit Of QIAGEN Amended First Statement Of Work Under Master Agreement
Wednesday, 20 Dec 2017 08:17am EST 

Dec 20 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC. 18. CO, UNIT OF QIAGEN, AMENDED FIRST STATEMENT OF WORK UNDER MASTER AGREEMENT - SEC FILING.HTG MOLECULAR DIAGNOSTICS - UNDER AGREEMENT, QIAGEN AGREED TO PAY CO LOW, SINGLE‑DIGIT MILLIONS OF DOLLARS FOR NEXT‑PHASE ACTIVITIES FOR PROJECT.  Full Article

HTG Molecular Diagnostics reports third quarter earnings
Tuesday, 7 Nov 2017 04:05pm EST 

Nov 7 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports 2017 third quarter earnings.Q3 loss per share $0.46.Sees FY 2017 revenue $10 million to $13 million.Q3 revenue $3.7 million.  Full Article

HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​
Monday, 18 Sep 2017 08:00am EDT 

Sept 18 (Reuters) - HTG Molecular Diagnostics Inc ::HTG Molecular Diagnostics Inc - ‍HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​.  Full Article

HTG Molecular Diagnostics Q2 loss per share $0.60
Tuesday, 8 Aug 2017 04:01pm EDT 

Aug 8 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports second quarter 2017 results.Q2 loss per share $0.60.Q2 revenue $1.8 million.Sees FY 2017 revenue $9.0 million to $12 million.  Full Article

BRIEF-HTG Promotes John Lubniewski To President And Chief Operating Officer

* HTG PROMOTES JOHN LUBNIEWSKI TO PRESIDENT AND CHIEF OPERATING OFFICER Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)